Panacea Biotec Limited has informed the Exchange regarding outcome of Board meeting held on May 30, 2025.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has informed the NSE about the outcome of its Board meeting held on May 30, 2025. The filing is a standard regulatory disclosure notifying the exchange that a board meeting took place. The actual details of what was discussed, approved, or decided have not been included in the provided text and would normally be found in the attached outcome document. Shareholders should refer to the detailed board meeting outcome filed separately with the exchange for specifics on any approvals, financial results, or corporate actions.
This is a procedural compliance disclosure with no visible direct impact on shareholders or the stock price until the detailed outcome (such as financial results, dividend, fundraising, or any strategic decision) is reviewed.